Endpoints News 生物医药· Elizabeth Cairns·· 2026-10-15AI 评分45
Osivax 流感疫苗 IIb 期试验失利后转向联合策略
Osivax pivots to combo approach after flu jab fails in Phase 2b
AI 导读
法国生物技术公司 Osivax 的主要流感疫苗在 IIb 期中期试验中表现失败。尽管该项目受挫,Osivax 仍对该管线抱有希望,并计划调整策略,将其与其他药物进行联合开发。
正文
Osivax’s lead flu vaccine has flopped in a mid-stage trial. But the French biotech still holds out hope for the program, and plans to combine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news